|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/496 | |
| A61K 47/12 | |||
| A61K 47/20 | |||
| A61K 47/22 | |||
| A61K 9/06 | |||
| A61K 9/08 | |||
| A61K 47/10 | |||
| A61K 47/32 | |||
| A61K 47/44 | |||
| A61K 9/70 |
| (11) | Number of the document | 2632463 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11836886.9 |
| Date of filing the European patent application | 2011-10-20 | |
| (97) | Date of publication of the European application | 2013-09-04 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/057080 |
| Date | 2011-10-20 |
| (87) | Number | WO 2012/058091 |
| Date | 2012-05-03 |
| (30) | Number | Date | Country code |
| 407591 P | 2010-10-28 | US |
| (72) |
PLAKOGIANNIS, Fotios, M., US
HOSSAIN, Muhammed, Anwar, US
|
| (73) |
Aequus Pharmaceuticals Inc.,
2820-200 Granville Street, Vancouver, BC V6C 1S4,
CA
|
| (54) | ARIPIPRAZOLE COMPOSITIONS AND METHODS FOR THEIR TRANSDERMAL DELIVERY |
| ARIPIPRAZOLE COMPOSITIONS AND METHODS FOR THEIR TRANSDERMAL DELIVERY |